US 9364448
Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation
granted A61KA61K31/122A61K8/35
Quick answer
US patent 9364448 (Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/122, A61K8/35, A61K8/40, A61P